中国人类免疫缺陷病毒感染的特殊群体抗病毒治疗专家共识

被引：11
作者：
中华医学会感染病学分会艾滋病学组
中华医学会热带病和寄生虫学分会艾滋病学组
机构：
[1] 上海市公共卫生临床中心感染科
[2] 中华医学会感染病学分会艾滋病学组
[3] 中华医学会热带病和寄生虫学分会艾滋病学组
来源：
中华传染病杂志 | 2017年 / 35卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R512.91 [获得性免疫缺陷综合征（AIDS艾滋病）];
学科分类号：
100401 ;
摘要：
<正>
引用
收藏
页码：1 / 4
页数：4
相关论文
共 12 条
[1]   2016年第2季度全国艾滋病性病疫情及主要防治工作进展 [J].
NCAIDS ;
NCSTD ;
China CDC .
中国艾滋病性病, 2016, 22 (08) :585-585
[2]   艾滋病合并结核病诊治现状 [J].
沈银忠 ;
卢洪洲 .
中国实用内科杂志, 2015, (08) :671-674
[3]   上海地区艾滋病相关性淋巴瘤11例临床分析 [J].
张仁芳 ;
王江蓉 ;
江雪艳 ;
刘莉 ;
齐唐凯 ;
郑毓芳 ;
沈银忠 ;
卢洪洲 .
中华内科杂志, 2009, (10)
[4]  
Dual treatment with lopinavir–ritonavir plus lamivudine versus triple treatment with lopinavir–ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): a randomised, open-label, non-inferiority trial[J] . José R Arribas,Pierre-Marie Girard,Roland Landman,Judit Pich,Josep Mallolas,María Martínez-Rebollar,Francisco X Zamora,Vicente Estrada,Manuel Crespo,Daniel Podzamczer,Joaquín Portilla,Fernando D
[5]  
Defining success with HIV pre-exposure prophylaxis: a prevention-effective adherence paradigm[J] . Jessica E. Haberer,David R. Bangsberg,Jared M. Baeten,Kathryn Curran,Florence Koechlin,K. Rivet Amico,Peter Anderson,Nelly Mugo,Francois Venter,Pedro Goicochea,Carlos Caceres,Kevin O’Reilly. AIDS . 2015 (11)
[6]  
Single-agent tenofovir versus combination emtricitabine plus tenofovir for pre-exposure prophylaxis for HIV-1 acquisition: an update of data from a randomised, double-blind, phase 3 trial[J] . Jared M Baeten,Deborah Donnell,Nelly R Mugo,Patrick Ndase,Katherine K Thomas,James D Campbell,Jonathan Wangisi,Jordan W Tappero,Elizabeth A Bukusi,Craig R Cohen,Elly Katabira,Allan Ronald,Elioda Tumwesigye,Edwin Were,Kenneth H Fife,James Kiarie,Carey Farquhar,Grace John-Stewart,Lara Kidoguchi,Robert
[7]  
Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study[J] . Robert M Grant,Peter L Anderson,Vanessa McMahan,Albert Liu,K Rivet Amico,Megha Mehrotra,Sybil Hosek,Carlos Mosquera,Martin Casapia,Orlando Montoya,Susan Buchbinder,Valdilea G Veloso,Kenneth Mayer,Suwat Chariyalertsak,Linda-Gail Bekker,Esper G Kallas,Mauro Schechter,Juan Guanira,Lane Bushman,David N Burns,James F Rooney,David V Glidden. The Lancet
[8]   Timing of Antiretroviral Therapy after Diagnosis of Cryptococcal Meningitis [J].
Boulware, David R. ;
Meya, David B. ;
Muzoora, Conrad ;
Rolfes, Melissa A. ;
Hullsiek, Katherine Huppler ;
Musubire, Abdu ;
Taseera, Kabanda ;
Nabeta, Henry W. ;
Schutz, Charlotte ;
Williams, Darlisha A. ;
Rajasingham, Radha ;
Rhein, Joshua ;
Thienemann, Friedrich ;
Lo, Melanie W. ;
Nielsen, Kirsten ;
Bergemann, Tracy L. ;
Kambugu, Andrew ;
Manabe, Yukari C. ;
Janoff, Edward N. ;
Bohjanen, Paul R. ;
Meintjes, Graeme .
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (26) :2487-2498
[9]   Assessment of Second-Line Antiretroviral Regimens for HIV Therapy in Africa [J].
Paton, Nicholas I. ;
Kityo, Cissy ;
Hoppe, Anne ;
Reid, Andrew ;
Kambugu, Andrew ;
Lugemwa, Abbas ;
van Oosterhout, Joep J. ;
Kiconco, Mary ;
Siika, Abraham ;
Mwebaze, Raymond ;
Abwola, Mary ;
Abongomera, George ;
Mweemba, Aggrey ;
Alima, Hillary ;
Atwongyeire, Dickens ;
Nyirenda, Rose ;
Boles, Justine ;
Thompson, Jennifer ;
Tumukunde, Dinah ;
Chidziva, Ennie ;
Mambule, Ivan ;
Arribas, Jose R. ;
Easterbrook, Philippa J. ;
Hakim, James ;
Walker, A. Sarah ;
Mugyenyi, Peter .
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (03) :234-247
[10]  
Ritonavir-boosted darunavir combined with raltegravir or tenofovir–emtricitabine in antiretroviral-naive adults infected with HIV-1: 96 week results from the NEAT001/ANRS143 randomised non-inferiority trial[J] . Fran?ois Raffi,Abdel G Babiker,Laura Richert,Jean-Michel Molina,Elizabeth C George,Andrea Antinori,Jose R Arribas,Jesper Grarup,Fleur Hudson,Christine Schwimmer,Juliette Saillard,Cédrick Wallet,Per O Jansson,Clotilde Allavena,Remko Van Leeuwen,Jean-Fran?ois Delfraissy,Stefano Vella
12